Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Eugene Liat Hui, Ong"'
Publikováno v:
Clinical and Experimental Dermatology. 47:2314-2317
We present an unusual case of an orange–brown penile lesion with a description of the histological findings. Click here for the corresponding questions to this CME article.
Publikováno v:
The American Journal of Dermatopathology. 45:47-50
Deficiency of adenosine deaminase type 2 (DADA2) is an autosomal recessive monogenic autoinflammatory syndrome that is classically characterised by polyarteritis nodosa, systemic vasculitis and stroke. The spectrum of disease manifestations has broad
Analysis by sex: observed numbers of people with NMSC who had a subsequent record of primary malignant cancer, risk ratios (RR) and 95% confidence intervals
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b3292e07c0a9e97c7ab3b7b7aaa9ddaa
https://doi.org/10.1158/1055-9965.22436544.v1
https://doi.org/10.1158/1055-9965.22436544.v1
Background: Conflicting evidence exists about whether people with a history of nonmelanoma skin cancer (NMSC) are at higher risk of subsequent primary malignant cancers than those without.Methods: An all England record-linked hospital and mortality d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b22a0844b45b6a010a349712d5638bb
https://doi.org/10.1158/1055-9965.c.6515466.v1
https://doi.org/10.1158/1055-9965.c.6515466.v1
Publikováno v:
The American Journal of dermatopathology. 41(3)
Cutaneous toxicities associated with BRAF inhibitor treatment in patients with metastatic melanoma have been well described. We present a rare association of granulomatous dermatitis in association with the BRAF inhibitor vemurafenib. Three patients
Publikováno v:
European Journal of Cancer. 50:2456-2462
BACKGROUND: There is evidence that people with Parkinson's disease (PD) have a decreased risk of developing cancer. PD has also variably been shown to be associated with an increased risk of cancers like melanoma and breast. We investigated this rela
Our recent study ([1][1]) is the largest of many of different designs aimed at investigating the relationship between Nonmelanoma skin cancer (NMSC) and subsequent primary malignancies. Our results are in line with the most comprehensive systematic r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::43bf71d5e270c80695d8a298597463e8
https://doi.org/10.1158/1055-9965.epi-14-0355
https://doi.org/10.1158/1055-9965.epi-14-0355
Publikováno v:
Cancer epidemiology, biomarkers and prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 23(3)
Background: Conflicting evidence exists about whether people with a history of nonmelanoma skin cancer (NMSC) are at higher risk of subsequent primary malignant cancers than those without. Methods: An all England record-linked hospital and mortality
Publikováno v:
Journal of the American Academy of Dermatology. 69(5)